TGA approves yet another use for Humira (adalimumab)

31 October 2016 - AbbVie clocks up another indication for its TNF-alfa inhibitor. ...

Read more →

TGA publishes AusPAR for Keytruda

18 October 2016 - The TGA has finally published an AusPAR for MSD's PD-1 inhibitor. ...

Read more →

TGA publishes AusPAR for Zurampic

14 October 2016 - The TGA has published an AusPAR for AstraZeneca's Zurampic. ...

Read more →

TGA boss warns about streamlining approvals

3 October 2016 - The head of the Therapeutic Goods Administration, John Skerritt, has warned that federal government reforms to ...

Read more →

Fast-track approval of medicines in Australia

30 September 2016 - The Australian Government has recently taken steps to fast track the registration of new medicines, generics, and ...

Read more →

TGA performance statistics report: July 2015 to June 2016

28 September 2016 - The TGA, through the Performance Statistics Report, provides detailed statistical information on its performance to stakeholders. ...

Read more →

Zinbryta approved by TGA

27 September 2016 - The TGA has approved Biogen's Zinbryta. ...

Read more →

TGA pre-submission phase option for prescription medicines

19 September 2016 - The pre-submission pilot for prescription medicines will conclude at the end of September 2016 and continue as ...

Read more →

Streamlined approvals means faster access to medicines for patients

15 September 2016 - Medicines Australia welcomes the commitment of the Australian Government to improve the way medicines are assessed for ...

Read more →

TGA approves Simponi for axial spondyloarthritis

15 September 2016 - The TGA has approved a new use for Simponi. ...

Read more →

New medicine approval process to allow quicker access to breakthrough drugs

15 September 2016 - The Federal Government is changing the way new medicines are approved to ensure Australians get access to ...

Read more →

TGA approves Odefsey

30 August 2016 - The TGA has approved Gilead's combination product for HIV-1 infection Odefsey. ...

Read more →

TGA approves Taltz

14 September 2016 - The TGA has approved Eli Lilly's Taltz (ixekizumab). ...

Read more →

TGA publishes AusPAR for Lenvima (lenvatinib mesylate)

9 September 2016 - The TGA has published an AusPAR for Eisai's vascular endothelial growth factor inhibitor inhibitor. ...

Read more →

TGA publishes AusPAR for Opdivo (nivolumab)

7 September 2016 - The TGA has published an AusPAR for BMS' Opdivo. ...

Read more →